Slimming effect by taking medicines
Not Applicable
Completed
- Conditions
- Healthy adult woman
- Registration Number
- JPRN-UMIN000033816
- Lead Sponsor
- Japan Clinical Trial Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects with food allergies 2. Subjects who are pregnant or lactating 3. Subjects who consume medicinal product which may influence the outcome of the study 4.Subjects who consume food which may influence the outcome of the study 5. Subjects who are judged as unsuitable for the study by the investigator for the other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare the sizes of the body before starting taking the test medicine and 8 weeks after taking it
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the slimming effects observed in JPRN-UMIN000033816 trial for healthy adult women?
How does the intervention in JPRN-UMIN000033816 compare to standard-of-care weight management strategies in terms of efficacy and safety?
Are there specific biomarkers identified in JPRN-UMIN000033816 that correlate with weight loss outcomes in healthy adult women?
What are the potential adverse events associated with the slimming medications tested in JPRN-UMIN000033816 and how are they managed?
What related compounds or combination therapies have shown similar weight management effects in trials involving healthy adult women?